SG Americas Securities LLC lowered its stake in ARK Genomic Revolution ETF (BATS:ARKG – Free Report) by 84.6% during the first quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 15,786 shares of the company’s stock after selling 86,735 shares during the quarter. SG Americas Securities LLC’s holdings in ARK Genomic Revolution ETF were worth $417,000 as of its most recent filing with the SEC.
A number of other large investors have also recently bought and sold shares of the stock. Sunbelt Securities Inc. increased its position in ARK Genomic Revolution ETF by 734.3% during the third quarter. Sunbelt Securities Inc. now owns 1,118 shares of the company’s stock worth $31,000 after buying an additional 984 shares in the last quarter. Strategic Wealth Investment Group LLC purchased a new stake in shares of ARK Genomic Revolution ETF in the second quarter valued at $38,000. AlphaCore Capital LLC purchased a new stake in shares of ARK Genomic Revolution ETF in the fourth quarter valued at $39,000. Wealth Watch Advisors INC boosted its stake in shares of ARK Genomic Revolution ETF by 274.4% during the fourth quarter. Wealth Watch Advisors INC now owns 1,928 shares of the company’s stock valued at $56,000 after acquiring an additional 1,413 shares during the last quarter. Finally, Advisory Services Network LLC acquired a new stake in shares of ARK Genomic Revolution ETF during the third quarter valued at $58,000.
ARK Genomic Revolution ETF Trading Down 1.7%
ARK Genomic Revolution ETF stock opened at $41.87 on Thursday. The stock has a 50-day moving average price of $34.35 and a 200 day moving average price of $31.04. ARK Genomic Revolution ETF has a 52 week low of $22.73 and a 52 week high of $44.47.
About ARK Genomic Revolution ETF
The ARK Genomic Revolution ETF (ARKG) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund is an actively managed fund that targets companies involved in the genomics industry. ARKG was launched on Oct 31, 2014 and is managed by ARK.
Featured Articles
- Five stocks we like better than ARK Genomic Revolution ETF
- A Market Panic Just Discounted the AI Highway’s Tollbooth
- Why Exxon Could Be the Market’s Next Big Comeback Stock
- The Market Just Got Shaken—These 3 ETFs May Come Out Stronger
- Meta Platforms’ Cloud Push: Growth Opportunity Versus AI Concerns
Want to see what other hedge funds are holding ARKG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for ARK Genomic Revolution ETF (BATS:ARKG – Free Report).
Receive News & Ratings for ARK Genomic Revolution ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ARK Genomic Revolution ETF and related companies with MarketBeat.com's FREE daily email newsletter.
